Bloomberg: Bayer in exclusive talks for Merck consumer health business

|About: Bayer A.G. (BAYZF)|By:, SA News Editor

Bayer (BAYZF, BAYRY) is in exclusive talks to buy Merck's (MRK) consumer health business for ~$14B, and a deal announcement is likely in the next few days, Bloomberg reports.

Reckitt Benckiser said yesterday it was no longer in active discussions for the business.

A deal would strengthen MRK’s core drug business while aiding Bayer's consumer products line by adding brands including Claritin.